Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance study

Uses of pharmacovigilance databases: an overview

(2020) Kévin Bihan et al.   THERAPIE

Variability in clinical presentation of diabetes mellitus during anti-PD-1 immunotherapy

(2019) M. Bastin et al.   DIABETES & METABOLISM

T-Lymphocyte Infiltration to Islets in the Pancreas of a Patient Who Developed Type 1 Diabetes After Administration of Immune Checkpoint Inhibitors

(2019) Sho Yoneda et al.   DIABETES CARE

Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system

(2019) Yinghong Zhai et al.   Journal for ImmunoTherapy of Cancer

Pharmacovigilance – The next chapter

(2019) Nicholas Moore et al.   THERAPIE

Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study

(2018) Marie-Léa Gauci et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors

(2018) Angeliki M. Stamatouli et al.   DIABETES

Cancer immunotherapy using checkpoint blockade

(2018) Antoni Ribas et al.   SCIENCE

Endocrine toxicity of cancer immunotherapy targeting immune checkpoints

(2018) Lee-Shing Chang et al.   ENDOCRINE REVIEWS

Fulminant diabetes induced by PD-1 and PD-L1 inhibitors: what about glucose variability?

(2018) Lucien Marchand et al.   ACTA DIABETOLOGICA

The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma

(2017) Emma S Scott et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies

(2017) David J. Byun et al.   Nature Reviews Endocrinology

Immune Checkpoint Blockade in Cancer Therapy

(2015) Michael A. Postow et al.   JOURNAL OF CLINICAL ONCOLOGY

Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)

(2012) Akihisa Imagawa et al.   Journal of Diabetes Investigation